glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer In vivo functional screens reveal
In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Frontiers Molecular subtypes based on ferroptosis related genes and tumor microenvironment infiltration characterization in small cell lung cancer
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



